Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME
Phase 4
- Conditions
- Diabetic Macular EdemaDiabetic RetinopathyRetinal Ischemia
- Interventions
- First Posted Date
- 2019-07-30
- Last Posted Date
- 2020-03-18
- Lead Sponsor
- Retina Macula Specialists of Miami, LLC
- Target Recruit Count
- 20
- Registration Number
- NCT04038125
- Locations
- 🇺🇸
Retina Macula Specialists of Miami, LLC, South Miami, Florida, United States
News
No news found